TITLE

COMMENTARY: Review: Oral antifungal therapy has low risk for adverse events in superficial dermatophytosis and onychomycosis

AUTHOR(S)
Shear, Neil H.
PUB. DATE
January 2008
SOURCE
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author comments on the study which examines the safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis. According to the author, the results in the study are not true for tinea corporis, hyperkeratoric tinea pedis, and foot onychomytosis, where oral antifungal therapy is usually the only treatment that leads to clearance.
ACCESSION #
28694443

 

Related Articles

  • Review: Oral antifungal therapy has low risk for adverse events in superficial dermatophytosis and onychomycosis.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p14 

    The article presents a study which examines the safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis. Here, the researcher use a randomized controlled trial. Study shows that oral antifungal therapy has low risk for adverse events in patients with superficial...

  • Second opinion.  // Mayo Clinic Health Letter;Mar2013, Vol. 31 Issue 3, p8 

    The article provides an answer to a question related to different human problems including fungal toenail infection and walking pneumonia.

  • Six Novel Antimycotics. Rubin, A.I.; Bagheri, B.; Scher, R.K. // American Journal of Clinical Dermatology;2002, Vol. 3 Issue 2, p71 

    We have reviewed six new antimycotic agents which have potential applications for human cutaneous and mucosal diseases. Information on these six drugs was obtained via an English language search of PubMed through the US National Library of Medicine. The antimycotic agents reviewed include...

  • Anidulafungin was noninferior to fluconazole for invasive candidiasis.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p15 

    The article presents a study which examines the effect of anidulafungin and fluconazole in treating patients with candidemia or other forms of invasive candidiasis. Here, the researchers use randomized, controlled, noninferiority trial. In patients with candidemia or invasive candidiasis, study...

  • COMMENTARY: Anidulafungin was noninferior to fluconazole for invasive candidiasis. Gea-Banacloche, Juan // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p15 

    The author comments on the study which examines the effect of anidulafungin and fluconazole in treating patients with candidemia or other forms of invasive candidiasis. According to the author, though fluconazole, amphotericin and echinocandins seem to have similar efficacy, choosing one over...

  • CME/CE. CASE #2. Thickened, painful, and yellow thumbnail. STERN, ESTHER // Clinical Advisor;Mar2014, Vol. 17 Issue 3, p75 

    No abstract available.

  • A fungus among us. Jesitus, John // Dermatology Times;Jul2009, Vol. 30 Issue 7, p50 

    The article presents several case studies which discusses how some antifungal treatments can provoke drug-induced subacute cutaneous lupus erythematosus. It also presents information on how to diagnose and treat onychomycosis and tines capitis. Moreover, it mentions case studies of a 45 year old...

  • The Role of Topical Antifungal Therapy for Onychomycosis and the Emergence of Newer Agents. DEL ROSSO, JAMES Q. // Journal of Clinical & Aesthetic Dermatology;Jul2014, Vol. 7 Issue 7, p10 

    Onychomycosis is a common infection of the nail unit that is usually caused by a dermatophyte (tinea unguium) and most frequently affects toenails in adults. In most cases, onychomycosis is associated with limited treatment options that are effective in achieving complete clearance in many...

  • OPTIONS FOR ONYCHOMYCOSIS. Cohen, Philip R. // Clinical Advisor;Aug2012, Vol. 15 Issue 8, p44 

    The article provides an answer to a question of what is an effective alternative to oral medications or topical ciclopirox (Penlac) for onychomycosis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics